B:concurrent chemoradiotherapy

2 trials

Sponsors

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Xiangya Hospital of Central South University

Conditions

Nasopharyngeal carcinomaesophageal squamous cell carcinoma

Phase 2

A multicenter, randomized, controlled, phase II trial for comparing radical concurrent chemoradiotherapy with/without Toripalimab (JS001) and consolidated immunotherapy in locally advanced esophageal squamous cell carcinoma

Active, not recruitingChiCTR2000032369

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Collegeesophageal squamous cell carcinoma

Start: 2020-06-01Updated: 2020-04-27

Phase 4

A prospective randomized controlled clinical trial of docetaxel plus cisplatin induction chemotherapy followed by concurrent chemoradiotherapy and concurrent chemoradiotherapy in the treatment of locally localized nasopharyngeal carcinoma

RecruitingChiCTR-IPR-17011605

Xiangya Hospital of Central South UniversityNasopharyngeal carcinoma

Start: 2017-06-07Updated: 2017-06-12